These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 93978)

  • 1. Testicular cancer: role of biological tumor markers.
    Pearson JC; Spaulding JT; Friedman MA
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunodetection of primary and secondary germ cell tumors.
    Van Cangh PJ; Ferrant A; Ninane J; Humblet Y; Deckers C
    Prog Clin Biol Res; 1985; 203():127-38. PubMed ID: 2421326
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
    Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
    Scardino PT; Cox HD; Waldmann TA; Mcintire KR; Mittemeyer B; Javadpour N
    J Urol; 1977 Dec; 118(6):994-9. PubMed ID: 72833
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum and cellular biologic tumor markers in patients with urologic cancer.
    Javadpour N
    Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers aid therapy of testicular cancer.
    JAMA; 1979 Jul; 242(4):320-1. PubMed ID: 87526
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of biologic markers in diagnosis and treatment of testicular cancer.
    Javadpour N
    Semin Oncol; 1979 Mar; 6(1):37-47. PubMed ID: 88072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 10. Testicular cancer. Clinical practice guidelines in oncology.
    Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in malignant tumors].
    Ogreid P
    Tidsskr Nor Laegeforen; 1980 Apr; 100(12):678-9. PubMed ID: 6158119
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK
    Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S; Arakawa S; Masuda M; Hamami G; Shimatani N; Itho N; Nakatsuka E; Fujii A; Ohono S; Ishigami J; Yoshimoto Y; Hattori M; Fujita T; Okada S
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):352-62. PubMed ID: 6157042
    [No Abstract]   [Full Text] [Related]  

  • 17. A multivariate analysis of prognostic factors in advanced stage of non seminomatous germ cell tumors of the testis (NSGCTT).
    Droz JP; Kramar A; Caillaud JM; Bellet D; Wibault P; Court BH
    Prog Clin Biol Res; 1985; 203():269-70. PubMed ID: 2421329
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of stage I, II testicular tumor based on tumor markers].
    Kamidono S; Arakawa S; Hamami G; Umezu K; Fujii A; Ishigami J
    Nihon Hinyokika Gakkai Zasshi; 1983 Aug; 74(8):1383-93. PubMed ID: 6202917
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of biologic markers: Memorial Hospital experience.
    Barzell WE; Whitmore WF
    Semin Oncol; 1979 Mar; 6(1):48-52. PubMed ID: 88073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.